For clarification: oral administration of glucocorticoids, which remains prohibited in-competition, includes, in particular, oromucosal, buccal, gingival and sublingual routes
BPC-157 in Practice: What Functional & Integrative Medicine Providers Should Know BPC-157 in Practice: What Functional & Integrative Medicine Providers Should Know | BPC-157 in Practice: What Functional & Integrative Medicine Providers Should Know Educational content for healthcare providers
Thymosin Beta-4 Heritage: Parent compound is endogenous and well-characterized Clinical Trials: RegeneRx trials showed generally favorable safety in ophthalmic and cardiac applications Cancer Concerns: Theoretical concerns about cell migration and tumor potential
, Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation, Springer Science and Business Media LLC, Nov
Over time, this may lead to lower B12 levels in the body
Definitely helped with weight loss and energy too